105 related articles for article (PubMed ID: 10226805)
21. A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit.
Twigg SM; Hardman KV; Baxter RC
Growth Horm IGF Res; 2000 Aug; 10(4):215-23. PubMed ID: 11032705
[TBL] [Abstract][Full Text] [Related]
22. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
23. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.
Beattie J; Phillips K; Shand JH; Szymanowska M; Flint DJ; Allan GJ
J Mol Endocrinol; 2005 Feb; 34(1):163-75. PubMed ID: 15691886
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3.
Campbell PG; Durham SK; Suwanichkul A; Hayes JD; Powell DR
Am J Physiol; 1998 Aug; 275(2):E321-31. PubMed ID: 9688635
[TBL] [Abstract][Full Text] [Related]
25. Circulating salmon 41-kDa insulin-like growth factor binding protein (IGFBP) is not IGFBP-3 but an IGFBP-2 subtype.
Shimizu M; Suzuki S; Horikoshi M; Hara A; Dickhoff WW
Gen Comp Endocrinol; 2011 May; 171(3):326-31. PubMed ID: 21354155
[TBL] [Abstract][Full Text] [Related]
26. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
27. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
[TBL] [Abstract][Full Text] [Related]
29. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5.
Nam TJ; Busby WH; Clemmons DR
Endocrinology; 1994 Oct; 135(4):1385-91. PubMed ID: 7523096
[TBL] [Abstract][Full Text] [Related]
30. Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides.
Hekim C; Riipi T; Weisell J; Närvänen A; Koistinen R; Stenman UH; Koistinen H
Biol Chem; 2010 Apr; 391(4):475-9. PubMed ID: 20180640
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.
Réhault S; Monget P; Mazerbourg S; Tremblay R; Gutman N; Gauthier F; Moreau T
Eur J Biochem; 2001 May; 268(10):2960-8. PubMed ID: 11358513
[TBL] [Abstract][Full Text] [Related]
32. Activity of human pregnancy insulin-like growth factor binding protein-3: determination by reconstituting recombinant complexes.
Yan X; Payet LD; Baxter RC; Firth SM
Endocrinology; 2009 Nov; 150(11):4968-76. PubMed ID: 19734278
[TBL] [Abstract][Full Text] [Related]
33. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes.
Arai T; Parker A; Busby W; Clemmons DR
J Biol Chem; 1994 Aug; 269(32):20388-93. PubMed ID: 7519608
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma.
Gui Y; Murphy LJ
J Clin Endocrinol Metab; 2001 May; 86(5):2104-10. PubMed ID: 11344214
[TBL] [Abstract][Full Text] [Related]
35. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions.
Rees C; Clemmons DR; Horvitz GD; Clarke JB; Busby WH
Endocrinology; 1998 Oct; 139(10):4182-8. PubMed ID: 9751498
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin.
Campbell PG; Durham SK; Hayes JD; Suwanichkul A; Powell DR
J Biol Chem; 1999 Oct; 274(42):30215-21. PubMed ID: 10514513
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I.
Nam TJ; Busby W; Clemmons DR
Endocrinology; 1997 Jul; 138(7):2972-8. PubMed ID: 9202242
[TBL] [Abstract][Full Text] [Related]
38. IGF dependent modulation of IGF binding protein (IGFBP) proteolysis by pregnancy-associated plasma protein-A (PAPP-A): multiple PAPP-A-IGFBP interaction sites.
Gaidamauskas E; Gyrup C; Boldt HB; Schack VR; Overgaard MT; Laursen LS; Oxvig C
Biochim Biophys Acta; 2013 Mar; 1830(3):2701-9. PubMed ID: 23671931
[TBL] [Abstract][Full Text] [Related]
39. Biological characterization and structure based prediction of insulin-like growth factor binding protein-5.
Sung M; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2010 Dec; 403(2):230-6. PubMed ID: 21074516
[TBL] [Abstract][Full Text] [Related]
40. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
Imai Y; Moralez A; Andag U; Clarke JB; Busby WH; Clemmons DR
J Biol Chem; 2000 Jun; 275(24):18188-94. PubMed ID: 10766744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
